SCHOTT Pharma AG & Co. KGaA (1SXP) - Cash Flow Conversion Efficiency

Latest as of September 2024: 0.096x

Based on the latest financial reports, SCHOTT Pharma AG & Co. KGaA (1SXP) has a cash flow conversion efficiency ratio of 0.096x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€75.97 Million ≈ $88.82 Million USD) by net assets (€792.27 Million ≈ $926.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 1SXP market cap overview for the company's overall valuation and market capitalisation.

SCHOTT Pharma AG & Co. KGaA - Cash Flow Conversion Efficiency Trend (2020–2024)

This chart illustrates how SCHOTT Pharma AG & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

SCHOTT Pharma AG & Co. KGaA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SCHOTT Pharma AG & Co. KGaA ranked by their cash flow conversion efficiency. Explore SCHOTT Pharma AG & Co. KGaA (1SXP) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
KCE Electronics Public Company Limited BK:KCE	0.048x
Proximus NV BR:PROX	0.076x
Zhejiang Publishing & Media Co Ltd SHG:601921	-0.028x
Corporativo Fragua S.A.B. de C.V MX:FRAGUAB	0.325x
Zhuzhou Kibing Group Co Ltd SHG:601636	0.047x
LandBridge Company LLC NYSE:LB	0.051x
Coface SA PA:COFA	0.021x
Mineralys Therapeutics, Inc. Common Stock NASDAQ:MLYS	-0.059x

Annual Cash Flow Conversion Efficiency for SCHOTT Pharma AG & Co. KGaA (2020–2024)

The table below shows the annual cash flow conversion efficiency of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. View SCHOTT Pharma AG & Co. KGaA share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-06-30	€792.27 Million ≈ $926.25 Million	€225.33 Million ≈ $263.43 Million	0.284x	+8.37%
2023-06-30	€692.18 Million ≈ $809.23 Million	€181.65 Million ≈ $212.37 Million	0.262x	+2.17%
2022-06-30	€709.04 Million ≈ $828.95 Million	€182.12 Million ≈ $212.92 Million	0.257x	-18.52%
2021-06-30	€419.42 Million ≈ $490.34 Million	€132.21 Million ≈ $154.57 Million	0.315x	-4.69%
2020-06-30	€315.66 Million ≈ $369.04 Million	€104.40 Million ≈ $122.05 Million	0.331x	--

About SCHOTT Pharma AG & Co. KGaA

XETRA:1SXP Germany Medical Instruments & Supplies

Market Cap

$4.09 Billion

€3.49 Billion EUR

Market Cap Rank

#5580 Global

#875 in Germany

Share Price

€23.20

Change (1 day)

+0.65%

52-Week Range

€12.96 - €23.50

All Time High

€41.20